Stocks and InvestingStocks and Investing
Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023
Thu, January 5, 2023

Geoff Meacham Initiated (AMLX) at Strong Buy and Held Target at $50 on, Jan 5th, 2023


Published on 2024-10-28 00:45:59 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $50 on, Jan 5th, 2023.

Geoff has made no other calls on AMLX in the last 4 months.



There are 4 other peers that have a rating on AMLX. Out of the 4 peers that are also analyzing AMLX, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $40 on, Friday, September 9th, 2022


These are the ratings of the 3 analyists that currently disagree with Geoff


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Monday, October 24th, 2022
  • Neena Bitritto-Garg of "Citigroup" Maintained at Strong Buy with Increased Target to $50 on, Monday, October 3rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $50 on, Thursday, September 8th, 2022